Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amicas agrees to Thoma Bravo buyout

This article was originally published in The Gray Sheet

Executive Summary

Private equity investment firm Thoma Bravo will acquire medical imaging IT firm Amicas for $217 million under a definitive agreement announced Dec. 28. Thoma Bravo will pay $5.35 per share for the company - a 21% premium over its Dec. 24 stock price close of $4.42. "With the additional capital and operational expertise available to Amicas through Thoma Bravo, we will be able to grow as the needs of our customers evolve and will be enabled to better serve our market," said Amicas CEO Stephen Kahane. Amicas, which makes picture archiving and communication systems and other medical imaging IT solutions, notes that it has 45 days to solicit potential alternative proposals under the agreement

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel